StockData
Prothena Corp Public Ltd Co logo

Prothena Corp Public Ltd Co (PRTA) income statement

PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3021% below fair value
$8.22−0.18 (-2.14%)

Close on Nov 20, 2026Market cap $421.99MP/E –Yield –

See a number that looks wrong?